The content of this webpage is for Australian healthcare professionals only.
ACTIKERALL
Resources
▼ This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. You can help by reporting any side effects you may get to your doctor, or directly at
www.tga.gov.au/reporting-problems
.
| WARNING: Actikerall® is intended for use only on mild and moderate solar keratosis. Actikerall® should not be applied on a total area greater than 25 square centimetres (cm2) at any one time. Use Actikerall® only on the face, forehead, or bald scalp. Do not use Actikerall on eyelids, lips, or mucous membranes. |
References
1. ACTIKERALL Consumer Medicine Information 2023. 2.
ACTIKERALL Product Information. 3.
Stockfleth E,
et al
. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
Br J Dermatol
. 2011;165(5):1101-8. 4.
Simon JC,
et al
. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
J Eur Acad Dermatol Venereol
. 2015;29(5):881-9. 5.
Martínez N,
et al
. Alternative lacquer removal techniques to remove 0.5% 5-fluorouracil/10% salicylic acid topical solutions for actinic keratosis. Presented at 14th EADO Congress; 6-9 November; Barcelona, Spain. 2018. 6.
https://www.cancervic.org.au/cancer-information/types-of-cancer/skin_cancers_non_melanoma/skin-cancer-overview.html [
accessed on 01 May 2023]. 7.
British Association of Dermatologists, Patient Information Leaflet Actinic Keratosis 2020, accessed from
https://www.skinhealthinfo.org.uk/wp-content/uploads/2018/11/Actinic-Keratoses-Update-Dec-2020-Lay-reviewed-Oct-2020.pdf
[accessed on 01 May 2023].
